Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sustained release
Pharma
Spiral winds up for sustained-release trial with $8M round
Spiral Therapeutics has raised $8.25 million to fund phase 2 development of a sustained-release treatment for a debilitating inner ear disorder.
Nick Paul Taylor
Jan 10, 2023 10:45am
Mayo, InSitu pen prolonged-release cancer co-development pact
Jan 3, 2023 7:15am
Re-Vana reels in $12M to develop sustained-release eye implants
Dec 6, 2022 10:26am
Iveric to develop sustained-release form of retinal disease drug
Jul 5, 2022 10:00am
Inflammasome gets Gates grant for dual HIV-birth control implant
Aug 10, 2021 9:55am
Regeneron scraps sustained-release Eylea alliance with Ocular
Aug 10, 2021 8:45am
